ALLIANCEBERNSTEIN L.P. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2024$502,445
+31.3%
138,797
+16.4%
0.00%
Q1 2024$382,619
-40.6%
119,196
-9.3%
0.00%
Q4 2023$643,693
-10.7%
131,366
-0.6%
0.00%
Q3 2023$720,468
-18.8%
132,1960.0%0.00%
Q2 2023$887,035
-24.0%
132,1960.0%0.00%
-100.0%
Q1 2023$1,167,291
+15.6%
132,1960.0%0.00%
Q4 2022$1,009,977
+7.3%
132,1960.0%0.00%
Q3 2022$941,000
-16.2%
132,196
-4.8%
0.00%
-100.0%
Q2 2022$1,123,000
+85.6%
138,821
+218.7%
0.00%
Q1 2022$605,000
-51.8%
43,554
-2.5%
0.00%
Q4 2021$1,254,000
-24.0%
44,687
-7.9%
0.00%
-100.0%
Q3 2021$1,650,000
-18.2%
48,536
-1.7%
0.00%0.0%
Q2 2021$2,018,000
+16.4%
49,398
+14.7%
0.00%0.0%
Q1 2021$1,734,000
-31.2%
43,063
+1.0%
0.00%0.0%
Q4 2020$2,522,000
+36.5%
42,651
+12.2%
0.00%0.0%
Q3 2020$1,848,000
+13.2%
38,001
+12.6%
0.00%0.0%
Q2 2020$1,633,000
+97.2%
33,751
+13.2%
0.00%0.0%
Q1 2020$828,000
+6.0%
29,821
+14.3%
0.00%
Q4 2019$781,000
+77.9%
26,091
+83.7%
0.00%
Q3 2019$439,000
-87.9%
14,201
-81.1%
0.00%
-100.0%
Q2 2019$3,623,00075,0000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2023
NameSharesValueWeighting ↓
Matrix Capital Management Company, LP 17,332,191$535,565,00013.21%
TIGER MANAGEMENT L.L.C. 1,115,411$34,466,00013.06%
VIKING GLOBAL INVESTORS LP 38,406,607$1,186,764,0006.18%
Senator Investment Group LP 5,113,085$146,145,0003.67%
Casdin Capital, LLC 463,125$14,310,562,0001.48%
Graticule Asia Macro Advisors LLC 356,326$11,010,0000.86%
Ratan Capital Management LP 41,272$1,275,0000.67%
Rock Springs Capital Management LP 545,000$16,841,0000.67%
MYDA Advisors LLC 34,000$1,051,0000.48%
Aristotle Atlantic Partners, LLC 50,459$1,559,0000.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders